Tech Company Financing Transactions

Corvus Pharmaceuticals Funding Round

Rock Springs Capital, Adams Street Partners and BlackRock joined a $75 million Series B funding round for Corvus Pharmaceuticals. The round was announced on 9/30/2015.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series B
Proceeds Purpose
The proceeds will be used to expand the company's research and development programs of multiple small molecule and antibody agents in immuno-oncology, including the initiation of a multicenter Phase 1B trial, which is expected to begin in the first quarter of 2016.

Company Information

Company Status
Mailing Address
863 Mitten Rd. 102
Burlingame, CA 94010
Email Address
Not Recorded
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer.
Corvus Pharmaceuticals LinkedIn Company Profile
Social Media
Corvus Pharmaceuticals Company Twitter Account
Company News
Corvus Pharmaceuticals News
Corvus Pharmaceuticals on Facebook
Corvus Pharmaceuticals on YouTube

Management Team

Email & Social
Chief Executive Officer
Richard Miller
  Richard Miller LinkedIn Profile  Richard Miller Twitter Account  Richard Miller News  Richard Miller on Facebook
Chief Financial Officer
Leiv Lea
  Leiv Lea LinkedIn Profile  Leiv Lea Twitter Account  Leiv Lea News  Leiv Lea on Facebook
Vice President
Long Kwei
  Long Kwei LinkedIn Profile  Long Kwei Twitter Account  Long Kwei News  Long Kwei on Facebook
VP - Bus. Development
Daniel Hunt
  Daniel Hunt LinkedIn Profile  Daniel Hunt Twitter Account  Daniel Hunt News  Daniel Hunt on Facebook
VP - Bus. Development
William Jones
  William Jones LinkedIn Profile  William Jones Twitter Account  William Jones News  William Jones on Facebook
VP - R & D
Joseph Buggy
  Joseph Buggy LinkedIn Profile  Joseph Buggy Twitter Account  Joseph Buggy News  Joseph Buggy on Facebook
VP - R & D
Erik Verner
  Erik Verner LinkedIn Profile  Erik Verner Twitter Account  Erik Verner News  Erik Verner on Facebook



Browse more venture capital transactions:

Prev: 9/30/2015: Bionova Medical venture capital transaction
Next: 9/30/2015: Norse venture capital transaction


Share this article


About Our VC Transactions Data

Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary